Capillary aerosol technology and capillary aerosol generators have been described in U.S. Pat. No. 5,743,251, the contents of which are hereby incorporated by reference in their entirety.
In accordance with one embodiment, an aerosol generation system, comprises: an aerosol generator wherein a liquid formulation is at least partially volatilized in a capillary passage and discharged from the capillary passage to form an aerosol; a pumping unit adapted to supply a liquid formulation to the capillary passage of the aerosol generator; and a fluidic element located between the pumping unit and the capillary passage of the aerosol generator, wherein the fluidic element increases the backpressure of the liquid formulation as the liquid formulation enters the capillary passage.
In accordance with a further embodiment, a method of producing an aerosol comprises: supplying a liquid material to a heated capillary passage at a flow rate of 20 μl/s such that a pressure of the liquid at an inlet to the capillary passage is at least 1000 psi (pounds per square inch); and generating an aerosol with the heated capillary.
Aerosols are useful in a wide variety of applications. For example, it is often desirable to treat respiratory ailments with, or deliver drugs by means of, aerosol sprays of finely divided particles of liquid and/or solid, e.g., powder, medicaments, etc., which are inhaled into a patient's lungs. Aerosols can be generated from a heated capillary aerosol generator by feeding a solution or suspension in a liquid state (i.e., a liquid formulation or liquid material) to a capillary while heating the capillary sufficiently such that the solution (or the carrier portion of the suspension) is volatilized, so that upon discharge from the heated capillary, the solution (or suspension) is in the form of an aerosol. The length of the capillary can depend on heat requirements dictated by, among other factors, the composition of the aerosol to be generated. A potential problem associated with directly heated capillary aerosol generators is broad temperature variations inside the capillary tube that may lead to overheating and substandard aerosol formation, resulting in clogging of the capillary tube and/or failure of the capillary aerosol generator.
It can be appreciated that an aerosol generation system can be used to aspirate a liquid material or formulation from a container closure system, and dispense it through an aerosol generator or capillary tube sub-assembly for delivery of a continuous aerosolization. It would be desirable to improve the reliability and the robustness of the capillary aerosol generation system by having a system and method, which can stabilize the nominal operating pressure within the capillary passage of an aerosol generation unit by increasing the threshold backpressure for aerosolization (i.e., the minimum pressure needed to keep the flow consistent and capillary wet) and reduces the pressure oscillation within the system as a result of the conversion of the liquid material or formulation to vapor and large particles within the liquid material or formulation.
In accordance with one embodiment, a fluidic element is located between a pumping unit and a capillary tube of an aerosol generator, wherein the fluidic element increases the backpressure of the liquid formulation, such that the thermally conductive heater block maximizes heat transfer substantially evenly and uniformly from the thermally conductive heater block to the capillary tube.
In operation, electrical leads transfer power from a power source to heater cartridges that are inserted into the thermally conductive heater block, thereby heating the thermally conductive heater block. When heated, the thermally conductive heater block transfers heat to the aerosol generation unit or capillary tube and thus substantially evenly and uniformly heats the capillary tube to a temperature sufficient to at least partially volatilize the liquid material or the liquid formulation that is introduced to the heated capillary tube. For example, the at least partially volatilized liquid material or liquid formulation can be driven through a restrictor to atomize the liquid material or formulation. The volatilized material mixes with air supplied by a heated sheath air source within an aerosol confinement member at a distal end of the heater block and forms an aerosol.
Referring to
In accordance with one embodiment, as shown in
The system 10 can also experience variations in nominal pressure within the capillary or capillary passage from run to run (within a unit), oscillations in pressure profiles, clogging of the exit orifice with nominal pressures below 1000 psi, and particles with sizes that are greater than the diameter of the exit orifice in the capillary system 10. For example, when the nominal pressure is below 1000 psi, the system 10 may experience a pulsating aerosol, which results in capillary operating pressure spikes. In addition, when these pressure spikes occur, the aerosol generation system 10 may not be capable of withstanding such high pressures and results in a clogging of the capillary. The disposable delivery packet components and the fittings that are in the delivery packet fail when a failure occurs, which results in non-operation of the unit. Accordingly, it would be desirable to provide a system and method for improving the reliability and the robustness of the capillary aerosol generator, wherein a liquid formulation is partially vaporized to form an aerosol for inhalation.
As shown in
In use, the aerosol generation unit 90 can include an indirect heating block assembly (not shown), which encases a heated capillary tube, heats a liquid material or liquid formulation 26, which is pumped through the aerosol generation unit at a constant and continuous rate by a pumping unit 50. The pumping unit 50 preferably includes two syringe pumps 52, 54 and a valving arrangement or assembly 60 (
Referring to
In accordance with one embodiment, the pumping unit 50 should be able to support backpressures of up to at least 2,000 psi, and more preferably up to 3,000 psi to 4,000 psi. In addition, the syringe pumps 52, 54 are preferably mounted in a fluid resistant enclosure, and can include a force sensor on each syringe-mounting bracket to monitor the plunger force during fluid delivery. The pumping capacity of the syringe pumps 52, 54 facilitate handling of highly viscous formulations such as a lung surfactant.
The aerosol generation unit 90 can include a heater or heating unit 72 in the form of a heater block assembly comprised of an upper or top assembly and a lower or bottom assembly, a thermocouple, and an aerosol generator in the form of a capillary passage or tube 70. The aerosol generation unit 90 includes a capillary passage 70 in which the liquid formulation 26 (
In accordance with one embodiment, a backpressure inducing fluidic element 100 can be introduced between the valve assembly 60 of the pumping unit 50 and the inlet of the capillary system of the aerosol generation unit 90. The fluidic element 100 introduces additional backpressure to the system 10, such that the nominal pressure or backpressure is increased above a desired threshold pressure (e.g., greater than 1200 psi). It can be appreciated that by increasing the backpressure of the system 10 above a desired threshold pressure, the fluidic element 100 provides the system 10 with a method to dampen the pressure oscillations within the system 10. In addition, the increased backpressure within the system 10 provides a means to shear the liquid formulation 26 (or liquid material) prior to entering the heated capillary tube 70, which prevents the exit orifice from becoming clogged with particles of the liquid formulation 26 having a greater diameter than the tipped capillary end.
As shown in
For example, in accordance with one embodiment, fluidic elements 100 comprised of tubular members 102 having an internal diameter 120 of 0.005 inches and 0.010 inches were implemented between the pumping unit 50 and the aerosol generation unit 90. As shown in
On the contrary as shown in
In accordance with another embodiment, as shown in
It can be appreciated that the fluidic element 100 can be a linear tubular member 102 as shown in
In accordance with one embodiment as shown in
In accordance with another embodiment, as shown in
In accordance with a further embodiment, as shown in
The fluidic element 100 also preferably includes a fluidic element housing 170 comprised of an outer casing member 172 and a base unit 174 having an outer distal surface 176 adapted to receive the circular disk or plate-like element 160. An O-ring or sealant ring 180 fits around an outer edge of the circular disk or plate-like element 160. The O-ring 180 is preferably an elastomeric material with a round (O-shaped) cross-section, which forms a mechanical seal for the fluidic element 100, which fits within the outer casing member 172 and the base unit 174 of the fluidic element housing 170.
In accordance with one embodiment, the liquid material or liquid formulation 26, such as a lung surfactant, which is contained within a formulation or dose packet 350 is prepared for delivery to a patient by initially heating the packet 350 on the hot plate/stirrer 300 to liquefy the formulation 26 to a desired viscosity (i.e., a highly viscous formulation) for delivery to the pumping unit 50. The pumping unit 50 and the valve assembly 60 supplies the formulation 26 at a constant and continuous rate to the aerosol generator (or aerosol generation unit) 90, which includes a capillary passage in which the liquid formulation is at least partially vaporized. The heater block heats the capillary passage to a temperature range effective to at least partially volatilize liquid formulation in the capillary passage or tube into an aerosol. The aerosol generator 90 also preferably includes at least one air passage arranged such that the source of air is heated by the heater body or block, and wherein the heated or warmed air is admixed with the aerosol produced by the aerosol generator 90. It can be appreciated that the system 10 can include a separate air heater 312 in the form of a discrete air heater that is remote to the capillary tube, in lieu of or in addition to the use of the heat generated at or about the capillary tube.
The transition adaptor or aerosol confinement member 190 captures the aerosols produced by the aerosol generator 90 and the capillary tube and directs the aerosol into a flow tube for delivery to the patient via a CPAP adaptor 310. The CPAP adaptor 310 preferably delivers aerosols to the patient at about 35 to 38 degrees Celsius and more preferably about 37 degrees Celsius for infants. It can be appreciated that by varying the length of a delivery hose or tubing 104, the delivery temperature of the aerosols can be delivered at a suitable or desirable temperature. The aerosol confinement member 190 is preferably sealed to the capillary tube of the aerosol generation unit 90, which prevents ambient air (in contrast to heated air delivered to the transition adaptor) from admixing with the aerosol produced by the aerosol generator or capillary tube. The transition adaptor or aerosol confinement member 190 can include a condensate trap 200 having at least one baffle therein and/or a drainage port at a lower end thereof adapted to attach to a condensate collection device or drain tube assembly. The admixing of the heated or warm air with the aerosol produced by the formulation reduces the amount of condensation from the capillary tube to be able to deliver an aerosol to the patient located at a remote location from the system 10 and the aerosol generation unit 90.
The system 10 preferably in drug delivery applications is adapted to provide an aerosol having average mass median particle diameters of less than 2 microns to facilitate deep lung penetration. It is also desirable, in certain drug delivery applications, to deliver medicaments at high flow rates, e.g., above 1 milligram per second. It can be appreciated that the source of liquid formulation preferably contains a lung surfactant adapted for delivery as an aerosol to an infant's lungs.
While various embodiments have been described, it is to be understood that variations and modifications may be resorted to as will be apparent to those skilled in the art. Such variations and modifications are to be considered within the purview and scope of the claims appended hereto.
This application claims priority to U.S. Patent Provisional Application No. 60/976,998, filed Oct. 2, 2007, which is incorporated herein by this reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
4575609 | Fassel et al. | Mar 1986 | A |
4960992 | Vestal et al. | Oct 1990 | A |
5743251 | Howell et al. | Apr 1998 | A |
6003512 | Gerde | Dec 1999 | A |
6276347 | Hunt | Aug 2001 | B1 |
6501052 | Cox et al. | Dec 2002 | B2 |
6640050 | Nichols et al. | Oct 2003 | B2 |
6772757 | Sprinkel, Jr. | Aug 2004 | B2 |
6804458 | Sprinkel, Jr. et al. | Oct 2004 | B2 |
6883516 | Hindle et al. | Apr 2005 | B2 |
7128067 | Byron et al. | Oct 2006 | B2 |
7147170 | Nguyen et al. | Dec 2006 | B2 |
7167776 | Maharajh et al. | Jan 2007 | B2 |
7173222 | Cox et al. | Feb 2007 | B2 |
20020079309 | Cox et al. | Jun 2002 | A1 |
20030108342 | Sherwood et al. | Jun 2003 | A1 |
20040223918 | Pham et al. | Nov 2004 | A1 |
20050000512 | Ganan-Calvo | Jan 2005 | A1 |
20050229926 | Fink et al. | Oct 2005 | A1 |
20050235991 | Nichols et al. | Oct 2005 | A1 |
20060163570 | Renn et al. | Jul 2006 | A1 |
20080087280 | Dhuper et al. | Apr 2008 | A1 |
Number | Date | Country |
---|---|---|
1077828 | Mar 1960 | DE |
0624379 | Nov 1994 | EP |
2543442 | Oct 1984 | FR |
546353 | Feb 1977 | SU |
WO9742993 | Nov 1997 | WO |
WO0138514 | May 2001 | WO |
WO03012565 | Feb 2003 | WO |
WO03053502 | Jul 2003 | WO |
WO2004022242 | Mar 2004 | WO |
WO2005003547 | Jan 2005 | WO |
WO2005106350 | Nov 2005 | WO |
WO2004076064 | Jul 2007 | WO |
WO2007102087 | Sep 2007 | WO |
WO2008042912 | Apr 2008 | WO |
Entry |
---|
International Search Report and Written Opinion mailed Mar. 17, 2009 for PCT/IB2008/003258. |
International Preliminary Report on Patentability issued Apr. 7, 2010 for PCT/IB2008/003258. |
Number | Date | Country | |
---|---|---|---|
20090310950 A1 | Dec 2009 | US |
Number | Date | Country | |
---|---|---|---|
60976998 | Oct 2007 | US |